文献速递关节外科

股骨打压植骨翻修髋关节置换的生存率与患者报告结局:4,102髋的系统综述与Meta分析

Survivorship and Patient-Reported Outcomes in Femoral Impaction Bone Grafting for Revision Hip Arthroplasty: A Systematic Review and Meta-Analysis of 4,102 Hips.
PubMed 文献 · J Arthroplasty · 2025-07-03

该系统综述与Meta分析纳入45项研究、共4,102髋(3,805例患者),评估股骨打压植骨(IBG)翻修全髋关节置换术后的假体生存率与患者报告结局。总体10年生存率为95%(CI 92-97),但数据异质性显著(I2=79%,P<0.01);Endo-Klinik III-IV级骨缺损者10年生存率显著低于I-II级(90.9% vs 97.4%,P=0.048);Harris髋关节评分术后显著改善(SMD 10.7,95%CI 8.26-13.05,I2=99%)。

要点

  • 股骨IBG翻修全髋10年总体生存率为95%(CI 92-97),数据异质性显著(I2=79%,P<0.01)。
  • EK III-IV级骨缺损者10年生存率显著低于I-II级(90.9% vs 97.4%,P=0.048)。
  • 患者年龄≥65岁与<65岁、短柄与长柄的10年生存率均无显著差异(P=0.23、P=0.86)。

核心结论

  • 股骨IBG翻修髋关节置换术显示较高的长期(10年)生存率(95%,CI 92-97%,I2=79%)。
  • 患者报告结局(Harris髋关节评分)术后显著改善(I2=92%),尤其在中度骨缺损(EK I-II期)病例中。
  • 严重骨缺损(EK III-IV期)髋的生存率较低(90%),无论是否附加固定。

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA指南,纳入报告股骨IBG翻修全髋关节置换且随访至少12个月的研究。
  • 采用随机效应模型与逆方差加权法进行Meta分析,异质性用Higgins和Thompson的I2统计量与Cochran Q检验评估。
  • 共纳入45项研究,涵盖3,805例患者的4,102髋。

主要发现

  • 股骨IBG总体10年生存率为95%(CI 92-97),数据异质性显著(I2=79%,P<0.01)。
  • EK III和IV级骨缺损者10年生存率显著低于EK I和II级(90.9% vs 97.4%,P=0.048)。
  • 患者年龄≥65岁与<65岁的10年生存率无显著差异(94.5% vs 96.6%,P=0.23)。
  • 短柄与长柄的10年生存率无显著差异(95.5% vs 94.8%,P=0.86)。
  • Harris髋关节评分术后显著改善(标准化均数差10.7,95%CI 8.26-13.05,I2=99%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 总体10年生存率数据存在显著异质性(I2=79%,P<0.01)。
  • Harris髋关节评分合并分析存在显著异质性(I2=99%;结论中写作I2=92%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Femoral impaction bone grafting (IBG) is widely used in revision total hip arthroplasty for cases with severe bone loss. The purpose of this systematic review and meta-analysis was to assess survivorship and patient-reported outcome measures (PROMs) following femoral IBG. METHODS: The systematic review followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Studies reporting on femoral IBG in revision total hip arthroplasty with a minimum follow-up of 12 months were included. A random-effects model and the inverse-variance weighting method were used for meta-analysis. Heterogeneity was assessed using Higgins and Thompson's I2 statistic and Cochran's Q test. RESULTS: The systematic search included a total of 45 studies, comprising 4,102 hips in 3,805 patients. The overall 10-year survivorship for femoral IBG was 95% (confidence interval 92 to 97), with significant data heterogeneity (I2 = 79%, P < 0.01). Patients who had higher Endo-Klinik (EK) grades of femoral bone loss (III and IV) had significantly lower 10-year survival rates (90.9 versus 97.4% for EK grades I and II, P = 0.048). Neither patient age (≥ 65 years: 94.5 versus < 65 years: 96.6%, P = 0.23) nor stem length (short stems: 95.5 versus long stems: 94.8%, P = 0.86) significantly affected 10-year survival outcomes. PROMs included the Harris Hip Score, which notably improved postsurgery (standardized mean difference: 10.7, 95% confidence interval: 8.26 to 13.05, I2 = 99%). CONCLUSIONS: Hip revision arthroplasty with femoral IBG demonstrates high long-term (10-year) survivorship rates (95%, 92 to 97%, I2 = 79%) and significant improvements in PROMs, specifically the Harris Hip Score (I2 = 92%), especially in cases with moderate bone loss (EK stages I and II). There was a lower survivorship (90%) in hips with severe bone defects (EK stages III and IV), regardless of additional fixation.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Klimko A, Andronic O, Lu VYZ, et al. Survivorship and Patient-Reported Outcomes in Femoral Impaction Bone Grafting for Revision Hip Arthroplasty: A Systematic Review and Meta-Analysis of 4,102 Hips. J Arthroplasty. 2025. PMID: 40513899. doi:10.1016/j.arth.2025.06.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。